Stryker Shares Rise 1.64% Amid Medtech Sector Rally Trading Volume Hits $560 Million Ranking 197th in Market Activity

Stryker (SYK) rose 1.64% on October 8, 2025, with a trading volume of $560 million, ranking 197th in market activity for the day. The stock’s performance reflects renewed investor interest in medtech equities amid broader sector volatility

Recent earnings releases highlighted a 4.2% increase in surgical robotics revenue year-over-year, driven by expanded adoption of Mako platform systems in orthopedic procedures. Analysts noted that the firm’s Q3 guidance for procedure growth in spine and trauma segments outperformed consensus estimates

Regulatory developments also influenced market sentiment, as the FDA cleared a new bone regeneration product line expected to generate $150 million in annual revenue by 2027. This approval aligns with Stryker’s strategic focus on high-margin biologics, reinforcing long-term growth expectations

To deliver a robust back-test we need to pin down a few practical details that the request doesn’t yet specify: 1. Universe • Which market(s) do we draw the “top-500 by volume” from – e.g. NYSE + NASDAQ only, or a global list? 2. Weighting & position size • Equal weight (1/500 each day) or volume-weighted / dollar-weighted? 3. Trade price assumptions • Enter at the same-day close and exit at next-day close (T+1), or enter at next-day open and exit at that day’s close? 4. Cost assumptions • Any brokerage/slippage you’d like applied, or assume frictionless trading? With those four details confirmed I can generate the daily rebalanced signals and run the back-test from 2022-01-01 through today